Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
13/07/2020 5:51 pm
Bloodwork question about agmatine. Baseline, four months in, and the numbers moved in a direction I did not expect.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took four months to be sure.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Happy to be corrected on any of the above.
13/07/2020 6:51 pm
Baseline first.